News
FibroNest digital pathology in liver biopsies from patients with MASH FibroNest digital pathology augmented image for ...
Modernized bilayered restoration for dentists who desire the highest levels of restorative realism IRVINE, CA / ACCESS ...
Strategic alliance positions CBDL for aggressive national growth through 100+ retail locations and new premium product lines ...
New Adult and Adolescent Programs Launching in May and June to Improve Access to Structured Mental Health Support ARLINGTON HEIGHTS, ILLINOIS / ACCESS Newswire / May 6, 2025 / Clarity Clinic, a ...
Expands Market Presence and Strengthens Customer Base in Academic Medical Centers CUPERTINO, CALIFORNIA / ACCESS Newswire / May 6, 2025 / Infinx Healthcare, a leading provider of AI-powered solutions ...
STOCKHOLM, SE / ACCESS Newswire / May 6, 2025 / Vicore Pharma Holding (STO:VICO) - The following resolutions were passed at the annual general meeting (the "AGM") of Vicore Pharma Holding AB (publ) on ...
SALT LAKE CITY, UT / ACCESS Newswire / May 6, 2025 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty and one-half cents ($.
Company continues to innovate and develop its SaaS-based platform to facilitate Rx-to-OTC switch in line with recent President Trump Executive Order NEW YORK, NY / ACCESS Newswire / May 6, 2025 / ...
SUDBURY, MASSACHUSETTS / ACCESS Newswire / May 6, 2025 / Nick Health Inc., a new digital health startup dedicated to transforming the cancer care journey, has officially launched its global platform, ...
FORT LAUDERDALE, F / ACCESS Newswire / May 6, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of ...
PARIS, FRANCE AND MONTREAL, QUÉBEC / ACCESS Newswire / May 6, 2025 / Tribun Health, a leader in digital pathology software and AI-powered diagnostic solutions, is proud to announce that it has been ...
Preclinical data supports the advancement of oral Ketamir-2 as a safe, next-generation alternative to ketamine, with ongoing momentum in Phase I clinical trial enrollment MIAMI, FL / ACCESS Newswire / ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results